BioSyent Inc. (TSXV:RX)

Canada · Delayed Price · Currency is CAD

15.80

0.00 (0.00%)

At close: Feb 25, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Business	35.03M	31.59M	27.93M	28.62M	22.33M
Pharmaceutical Business Growth	10.89%	13.12%	-2.42%	28.15%	4.24%
Total	35.03M	31.59M	27.93M	28.62M	22.33M
Total Growth	10.89%	13.12%	-2.42%	28.15%	4.24%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Canada	33.83M	30.30M	27.02M	26.81M	21.88M
Canada Growth	11.66%	12.16%	0.77%	22.52%	10.44%
United States	266.56K	241.81K	224.95K	183.99K	224.90K
United States Growth	10.23%	7.49%	22.26%	-18.19%	32.87%
Middle East	929.98K	1.05M	683.58K	1.62M	225.14K
Middle East Growth	-11.24%	53.27%	-57.90%	621.21%	-84.38%
Total	35.03M	31.59M	27.93M	28.62M	22.33M
Total Growth	10.89%	13.12%	-2.42%	28.15%	4.24%

Source: S&P Global Market Intelligence.